Literature DB >> 62017

Suppression by autogenous complementary idiotypes: the priority of the first response.

D A Rowley, H Köhler, H Schreiber, S T Kaye, I Lorbach.   

Abstract

Complementary idiotypes or antibodies are considered to have combining site structures which are at least partly directed against each other. Complementary antibodies were induced in A/He mice by immunization with phosphorylcholine (PC)-containing antigens and by immunization with the PC-binding IgA myeloma protein TEPC-15 (T15). Both responses were monitored by enumerating plaque-forming cells (PFC) and assaying serum antibody levels against the corresponding antigens. Mice immunized at least three times with T15 in adjuvants had markedly suppressed responses to subsequent immunization with PC; similarly, mice preimmunized multiple times with PC had suppressed responses to immunizations with T15. In contrast, mice immunized with T15 in the interval between "primary" and "secondary" immunizations with PC had undiminished PFC responses to both antigens but significantly decreased antibody titers to PC. Simultaneous responses were also induced by immunizations with T15 superimposed on weekly immunizations with PC; with this regime, immunization with T15 actually enhanced the PFC response to PC, but serum antibody to PC was significantly lower than for mice immunized with PC only. Levels of serum antibody to PC were probably lower, either because anti-PC antibody was complexed with the complementary antibody directed against T15, or because the antibody directed against T15 prevented synthesis and/or release of anti-PC antibody by cells in vivo. Thus, an established prior autogenous immune response can dramatically suppress a subsequent primary complementary response, but the effects of complementary responses on each other are more complex with different sequences of immunization. Also, the effects of variables such as the amounts and ratios of the classes of antibodies on regulation of complementary responses remain to be defined.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62017      PMCID: PMC2190429          DOI: 10.1084/jem.144.4.946

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Specific suppression of immune responses.

Authors:  D A Rowley; F W Fitch; F P Stuart; H Köhler; H Cosenza
Journal:  Science       Date:  1973-09-21       Impact factor: 47.728

Review 2.  Antigen-binding myeloma proteins in mice.

Authors:  M Potter
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

3.  Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody.

Authors:  H Cosenza; H Köhler
Journal:  Science       Date:  1972-06-02       Impact factor: 47.728

4.  Studies of idiotypic antibodies. Production and characterization of autoantiidiotypic antisera.

Authors:  L S Rodkey
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

5.  Quantitative investigations of idiotypic antibodies. V. Factors affecting the persistence and replacement of clones of antibody-producing cells.

Authors:  S B Spring; K W Schroeder; A Nisonoff
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Induction of antiphosphorylcholine antibody formation by anti-idiotypic antibodies.

Authors:  E Trenkner; R Riblet
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

7.  Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies.

Authors:  J L Claflin; J M Davie
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

8.  Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine.

Authors:  R Lieberman; M Potter; E B Mushinski; W Humphrey; S Rudikoff
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

9.  Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays.

Authors:  P Wernet; T Feizi; H G Kunkel
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

10.  Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells.

Authors:  J L Claflin; R Lieberman; J M Davie
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  15 in total

1.  Clonal dominance: loss and restoration in adoptive transfer.

Authors:  D R Kaplan; J Quintans; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

2.  Use of anti-idiotypic antibodies as cell-surface receptor probes.

Authors:  K Sege; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Induction of anti-DNA autoanti-idiotypic antibodies in (NZB X NZW)F1 mice: possible role for specific immune suppression.

Authors:  L Jacob; F Tron
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

4.  A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens.

Authors:  D A Rowley; R M Stach
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

5.  Generation of idiotype-specific T cell help through network perturbation.

Authors:  K Gleason; S Pierce; H Köhler
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

6.  Simultaneous complementary idiotypic responses: absence of reciprocal regulation.

Authors:  D A Rowley; G W Miller; I Lorbach
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

7.  Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes.

Authors:  Y Dohi; A Nisonoff
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

8.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VII. Idiotype-specific suppression of plaque-forming cell responses.

Authors:  D H Sherr; S T Ju; J Z Weinberger; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

9.  Deregulation of idiotype expression. Induction of tolerance in an anti-idiotypic response.

Authors:  L Ortiz-Ortiz; W O Weigle; D E Parks
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

10.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. IX. Characterization of Idiotype-specific effector-phase suppressor cells on plaque-forming cell responses in vitro.

Authors:  D H Sherr; M E Dorf
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.